BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith BS, Yogaratnam D, Levasseur-Franklin KE, Forni A, Fong J. Introduction to drug pharmacokinetics in the critically ill patient. Chest. 2012;141:1327-1336. [PMID: 22553267 DOI: 10.1378/chest.11-1396] [Cited by in Crossref: 130] [Cited by in F6Publishing: 132] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Allen JM, Surajbali D, Q Nguyen D, Kuczek J, Tran M, Hachey B, Feild C, Shoulders BR, Smith SM, Voils SA. Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study. Ann Pharmacother 2022;:10600280221125919. [PMID: 36154486 DOI: 10.1177/10600280221125919] [Reference Citation Analysis]
2 Ewoldt TMJ, Abdulla A, Hunfeld N, Li L, Smeets TJL, Gommers D, Koch BCP, Endeman H. The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative review. Expert Opin Drug Metab Toxicol 2022. [PMID: 35912845 DOI: 10.1080/17425255.2022.2106215] [Reference Citation Analysis]
3 Qi Y, Liu G. A UPLC-MS/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM. Journal of Pharmaceutical and Biomedical Analysis 2022. [DOI: 10.1016/j.jpba.2022.114964] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Valentine K, Kummick J. PICU Pharmacology. Pediatr Clin North Am 2022;69:509-29. [PMID: 35667759 DOI: 10.1016/j.pcl.2022.01.011] [Reference Citation Analysis]
5 Hegde A. Drug Levels in ICU – T or F. Indian Journal of Critical Care Medicine 2022;26:663-663. [DOI: 10.5005/jp-journals-10071-24261] [Reference Citation Analysis]
6 Forsberg J, Bedard E, Mahmoud SH. Bioavailability of Orally Administered Drugs in Critically Ill Patients. J Pharm Pract 2022;:8971900221100205. [PMID: 35521821 DOI: 10.1177/08971900221100205] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu Z, Lan J, Wang X, Wu Y, Yao F, Wang Y, Zhao BX, Wang Y, Chen J, Chen C. Population Pharmacokinetics of Caspofungin and Dose Simulations in Heart Transplant Recipients. Antimicrob Agents Chemother 2022;:e0224921. [PMID: 35389237 DOI: 10.1128/aac.02249-21] [Reference Citation Analysis]
8 Sanz Codina M, Zeitlinger M. Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review. Clin Pharmacokinet 2022. [PMID: 35218003 DOI: 10.1007/s40262-021-01102-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Lizza BD, Raush N, Micek ST. Antibiotic Optimization in the Intensive Care Unit. Semin Respir Crit Care Med 2022;43:125-30. [PMID: 35172362 DOI: 10.1055/s-0041-1740972] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Torbic H, Hohlfelder B, Krishnan S, Tonelli AR. A Review of Pulmonary Arterial Hypertension Treatment in Extracorporeal Membrane Oxygenation: A Case Series of Adult Patients. J Cardiovasc Pharmacol Ther 2022;27:10742484211069005. [PMID: 35006031 DOI: 10.1177/10742484211069005] [Reference Citation Analysis]
11 Sonesson A, Bjørnsdottir I, Christensen JK. Meeting report: 3rd workshop of the peptide ADME discussion group. Xenobiotica 2021;:1-5. [PMID: 34919491 DOI: 10.1080/00498254.2021.2020377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Barra ME, Edlow BL, T Lund J, DeSanctis KS, Vetrano J, Reilly-Tremblay C, R Zhang E, G Bodien Y, Brown EN, Solt K. Stability of extemporaneously prepared preservative-free methylphenidate 5 mg/mL intravenous solution. Am J Health Syst Pharm 2021:zxab420. [PMID: 34788364 DOI: 10.1093/ajhp/zxab420] [Reference Citation Analysis]
13 Van Daele R, Wauters J, Lagrou K, Denooz R, Hayette MP, Gijsen M, Brüggemann RJ, Debaveye Y, Spriet I. Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients. Microorganisms 2021;9:2068. [PMID: 34683388 DOI: 10.3390/microorganisms9102068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Maguigan KL, Al-Shaer MH, Peloquin CA. Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach. Antibiotics (Basel) 2021;10:1154. [PMID: 34680734 DOI: 10.3390/antibiotics10101154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Van Daele R, Wauters J, Vandenbriele C, Lagrou K, Vos R, Debaveye Y, Spriet I. Interaction between flucloxacillin and azoles: Is isavuconazole next? Mycoses 2021;64:1508-11. [PMID: 34553797 DOI: 10.1111/myc.13373] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Sakuraya M, Yoshida T, Sasabuchi Y, Yoshihiro S, Uchino S. Clinical prediction scores and early anticoagulation therapy for new-onset atrial fibrillation in critical illness: a post-hoc analysis. BMC Cardiovasc Disord 2021;21:423. [PMID: 34496749 DOI: 10.1186/s12872-021-02235-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Bass GA, Dzierba AL, Taylor B, Lane-Fall M, Kaplan LJ. Tertiary peritonitis: considerations for complex team-based care. Eur J Trauma Emerg Surg 2021. [PMID: 34302503 DOI: 10.1007/s00068-021-01750-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Van Daele R, Brüggemann RJ, Dreesen E, Depuydt P, Rijnders B, Cotton F, Fage D, Gijsen M, Van Zwam K, Debaveye Y, Wauters J, Spriet I. Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation. J Antimicrob Chemother 2021;76:1234-41. [PMID: 33517360 DOI: 10.1093/jac/dkab012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Póvoa P, Moniz P, Pereira JG, Coelho L. Optimizing Antimicrobial Drug Dosing in Critically Ill Patients. Microorganisms 2021;9:1401. [PMID: 34203510 DOI: 10.3390/microorganisms9071401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
20 Barreto EF, Webb AJ, Pais GM, Rule AD, Jannetto PJ, Scheetz MH. Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling? Crit Care Explor 2021;3:e0446. [PMID: 34136822 DOI: 10.1097/CCE.0000000000000446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
21 Celestin MN, Musteata FM. Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States. J Pharm Sci 2021:S0022-3549(21)00283-5. [PMID: 34089711 DOI: 10.1016/j.xphs.2021.05.018] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
22 Nappi F, Iervolino A, Avtaar Singh SS. Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents. Metabolites 2021;11:341. [PMID: 34070672 DOI: 10.3390/metabo11060341] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
23 Dhondt L, Croubels S, Temmerman R, De Cock P, Meyer E, Van Den Broeck W, De Paepe P, Devreese M. The Development of a Juvenile Porcine Augmented Renal Clearance Model Through Continuous Infusion of Lipopolysaccharides: An Exploratory Study. Front Vet Sci 2021;8:639771. [PMID: 33996970 DOI: 10.3389/fvets.2021.639771] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Gasperetti T, Welte R, Oberacher H, Marx J, Lorenz I, Schellongowski P, Staudinger T, Burgmann K, Eller P, Santner T, Griesmacher A, Pfisterer H, Eschertzhuber S, Aigner M, Joannidis M, Bellmann R. Penetration of echinocandins into wound secretion of critically ill patients. Infection 2021;49:747-55. [PMID: 33877638 DOI: 10.1007/s15010-021-01604-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Ong CLJ, Goh PSJ, Teo MM, Lim TP, Goh KKK, Ang XY, Lim LJK, Jamaludin NHB, Ang BT, Kwa LHA. Pharmacokinetics of levetiracetam in neurosurgical ICU patients. J Crit Care 2021;64:255-61. [PMID: 34051579 DOI: 10.1016/j.jcrc.2021.04.013] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
26 Vinarov Z, Abrahamsson B, Artursson P, Batchelor H, Berben P, Bernkop-Schnürch A, Butler J, Ceulemans J, Davies N, Dupont D, Flaten GE, Fotaki N, Griffin BT, Jannin V, Keemink J, Kesisoglou F, Koziolek M, Kuentz M, Mackie A, Meléndez-Martínez AJ, McAllister M, Müllertz A, O'Driscoll CM, Parrott N, Paszkowska J, Pavek P, Porter CJH, Reppas C, Stillhart C, Sugano K, Toader E, Valentová K, Vertzoni M, De Wildt SN, Wilson CG, Augustijns P. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network. Adv Drug Deliv Rev 2021;171:289-331. [PMID: 33610694 DOI: 10.1016/j.addr.2021.02.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
27 Wicha SG, Märtson AG, Nielsen EI, Koch BCP, Friberg LE, Alffenaar JW, Minichmayr IK; International Society of Anti-Infective Pharmacology (ISAP), the PK/PD study group of the European Society of Clinical Microbiology, Infectious Diseases (EPASG). From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics. Clin Pharmacol Ther 2021;109:928-41. [PMID: 33565627 DOI: 10.1002/cpt.2202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
28 Phe K, Heil EL, Tam VH. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review. J Infect Dis 2020;222:S132-41. [PMID: 32691832 DOI: 10.1093/infdis/jiaa118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
29 Huang Y, Yang J, Xie J, Liu L, Liu S, Guo F, Qiu H, Yang Y. Association Between Pathophysiology and Volume of Distribution Among Patients With Sepsis or Septic Shock Treated With Imipenem: A Prospective Cohort Study. J Infect Dis 2020;221:S272-8. [PMID: 32176787 DOI: 10.1093/infdis/jiz651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Thibault C, Massey SL, Naim MY, Abend NS, Zuppa AF. Population Pharmacokinetics of IV Phenobarbital in Neonates After Congenital Heart Surgery. Pediatr Crit Care Med 2020;21:e557-65. [PMID: 32224827 DOI: 10.1097/PCC.0000000000002341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Skov K, Graudal NA, Jürgens G. The effect of activated charcoal on drug exposure following intravenous administration: A meta-analysis. Basic Clin Pharmacol Toxicol 2021;128:568-78. [PMID: 33386684 DOI: 10.1111/bcpt.13553] [Reference Citation Analysis]
32 Boullata JI. Enteral Medication for the Tube-Fed Patient: Making This Route Safe and Effective. Nutr Clin Pract 2021;36:111-32. [PMID: 33373487 DOI: 10.1002/ncp.10615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Peterson EL, Chittick PJ, Richardson CL. Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report. Transpl Infect Dis 2021;23:e13545. [PMID: 33316840 DOI: 10.1111/tid.13545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
34 Der-Nigoghossian C, Tesoro EP, Strein M, Brophy GM. Principles of Pharmacotherapy of Seizures and Status Epilepticus. Semin Neurol 2020;40:681-95. [PMID: 33176370 DOI: 10.1055/s-0040-1718721] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Pruskowski KA. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients. Surg Infect (Larchmt) 2021;22:77-82. [PMID: 33164665 DOI: 10.1089/sur.2020.375] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Hashemian SM, Farhadi T, Velayati AA. Caspofungin: a review of its characteristics, activity, and use in intensive care units. Expert Rev Anti Infect Ther 2020;18:1213-20. [PMID: 32662712 DOI: 10.1080/14787210.2020.1794817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Murdock JL, Duco MR, Reeves DJ. Tolerability of Highly Protein Bound Targeted Oral Oncolytic Drugs in Patients With Hypoalbuminemia: A Retrospective Analysis. Ann Pharmacother 2021;55:165-73. [PMID: 32674695 DOI: 10.1177/1060028020942485] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Liu X, Liu D, Pan Y, Li Y. Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta-analysis. J Clin Pharm Ther 2020;45:1207-17. [PMID: 32672361 DOI: 10.1111/jcpt.13211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Chai MG, Cotta MO, Abdul-Aziz MH, Roberts JA. What Are the Current Approaches to Optimising Antimicrobial Dosing in the Intensive Care Unit? Pharmaceutics 2020;12:E638. [PMID: 32645953 DOI: 10.3390/pharmaceutics12070638] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
40 Sutiman N, Koh JC, Watt K, Hornik C, Murphy B, Chan YH, Lee JH. Pharmacokinetics Alterations in Critically Ill Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review. Front Pediatr 2020;8:260. [PMID: 32670992 DOI: 10.3389/fped.2020.00260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
41 Brunsdon P, Saluja B, Sahajwalla C. Clinical Pharmacology Considerations for Developing Small-Molecule Treatments for COVID-19. J Clin Pharmacol 2020;60:1147-54. [PMID: 32579707 DOI: 10.1002/jcph.1697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
42 Van Daele R, Spriet I, Maertens J. Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation. Expert Opinion on Drug Metabolism & Toxicology 2020;16:539-50. [DOI: 10.1080/17425255.2020.1764939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Kleiber N, Calvier E, Mooij MG, Krekels EHJ, Vaes WHJ, Tibboel D, Knibbe CAJ, de Wildt SN. Enteral Acetaminophen Bioavailability in Pediatric Intensive Care Patients Determined With an Oral Microtracer and Pharmacokinetic Modeling to Optimize Dosing. Crit Care Med 2019;47:e975-83. [PMID: 31609773 DOI: 10.1097/CCM.0000000000004032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
44 Renew JR, Ratzlaff R, Hernandez-Torres V, Brull SJ, Prielipp RC. Neuromuscular blockade management in the critically Ill patient. J Intensive Care 2020;8:37. [PMID: 32483489 DOI: 10.1186/s40560-020-00455-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
45 Dingman JS, Smith ZR, Coba VE, Peters MA, To L. Argatroban dosing requirements in extracorporeal life support and other critically ill populations. Thrombosis Research 2020;189:69-76. [DOI: 10.1016/j.thromres.2020.02.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Aréchiga-Alvarado NA, Medellín-Garibay SE, Milán-Segovia RDC, Ortiz-Álvarez A, Magaña-Aquino M, Romano-Moreno S. Population Pharmacokinetics of Amikacin Administered Once Daily in Patients with Different Renal Functions. Antimicrob Agents Chemother 2020;64:e02178-19. [PMID: 32041715 DOI: 10.1128/AAC.02178-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
47 Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75:2950-73. [PMID: 32311448 DOI: 10.1016/j.jacc.2020.04.031] [Cited by in Crossref: 1202] [Cited by in F6Publishing: 1593] [Article Influence: 601.0] [Reference Citation Analysis]
48 Webster LR, Hale ME, Yamada T, Wild JE. A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy. J Pain Res 2020;13:605-12. [PMID: 32280263 DOI: 10.2147/JPR.S237833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
49 Kalaria SN, Gopalakrishnan M, Heil EL. A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients. Antimicrob Agents Chemother 2020;64:e02093-19. [PMID: 31871076 DOI: 10.1128/AAC.02093-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
50 Gorog DA, Price S, Sibbing D, Baumbach A, Capodanno D, Gigante B, Halvorsen S, Huber K, Lettino M, Leonardi S, Morais J, Rubboli A, Siller-Matula JM, Storey RF, Vranckx P, Rocca B. Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J Cardiovasc Pharmacother 2021;7:125-40. [PMID: 32049278 DOI: 10.1093/ehjcvp/pvaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
51 Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS. Gastrointestinal pain. Nat Rev Dis Primers. 2020;6:1. [PMID: 31907359 DOI: 10.1038/s41572-019-0135-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
52 Witcher R, Tracy J, Santos L, Chopra A. Outcomes and Adverse Effects With Peramivir for the Treatment of Influenza H1N1 in Critically Ill Pediatric Patients. J Pediatr Pharmacol Ther 2019;24:497-503. [PMID: 31719811 DOI: 10.5863/1551-6776-24.6.497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Prisco L, Ganau M, Aurangzeb S, Moswela O, Hallett C, Raby S, Fitzgibbon K, Kearns C, Sen A. A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care. Seizure 2020;75:153-64. [PMID: 31623937 DOI: 10.1016/j.seizure.2019.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
54 Rali P, Gangemi A, Moores A, Mohrien K, Moores L. Direct-Acting Oral Anticoagulants in Critically Ill Patients. Chest 2019;156:604-18. [PMID: 31251908 DOI: 10.1016/j.chest.2019.05.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Plummer MP, Hermanides J, Deane AM. Incretin Physiology and Pharmacology in the Intensive Care Unit. Critical Care Clinics 2019;35:341-55. [DOI: 10.1016/j.ccc.2018.11.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
56 Torbic H. Management of Pulmonary Arterial Hypertension in the ICU. J Pharm Pract 2019;32:303-13. [PMID: 30909801 DOI: 10.1177/0897190019838110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
57 Mendes JJ, Silva MJ, Miguel LS, Gonçalves MA, Oliveira MJ, Oliveira CDL, Gouveia J. Sociedade Portuguesa de Cuidados Intensivos guidelines for stress ulcer prophylaxis in the intensive care unit. Rev Bras Ter Intensiva 2019;31:5-14. [PMID: 30843949 DOI: 10.5935/0103-507X.20190002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Gao J, Yu J, Xu P, Chen J, Gao G, Li B, Sun L. Established UPLC-MS/MS procedure for multicomponent quantitative analysis in rat plasma: A contrastive pharmacokinetics study of Qiangshen tablet in normal and kidney yang deficiency syndrome models. Journal of Chromatography B 2019;1106-1107:35-42. [DOI: 10.1016/j.jchromb.2018.12.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
59 Nguyen H, Pan A, Smollin C, Cantrell LF, Kearney T. An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System. J Clin Pharm Ther 2019;44:327-34. [DOI: 10.1111/jcpt.12796] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
60 Torres A, Motos A, Battaglini D, Li Bassi G. Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects. Crit Care 2018;22:343. [PMID: 30558658 DOI: 10.1186/s13054-018-1958-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
61 Gibson BH, Sharpe JP, Lewis RH, Newell JS, Swanson JM, Wood GC, Fabian TC, Croce MA, Magnotti LJ. Use of Aerosolized Antibiotics in Gram-Negative Ventilator-Associated Pneumonia in Trauma Patients. The American Surgeon 2018;84:1906-12. [DOI: 10.1177/000313481808401236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Charlton M, Thompson JP. Pharmacokinetics in sepsis. BJA Educ 2019;19:7-13. [PMID: 33456848 DOI: 10.1016/j.bjae.2018.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
63 Tao J, Zhao M, Jiang S, Zhang W, Xu B, Duan J. UPLC-Q-TOF/MS-based metabolic profiling comparison of four major bioactive components in normal and CKD rat plasma, urine and feces following oral administration of Cornus officinalis Sieb and Rehmannia glutinosa Libosch herb couple extract. Journal of Pharmaceutical and Biomedical Analysis 2018;161:254-61. [DOI: 10.1016/j.jpba.2018.08.051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
64 Yang QT, Zhai YJ, Chen L, Zhang T, Yan Y, Meng T, Liu LC, Chen LM, Wang X, Dong YL. Whole-body physiology-based pharmacokinetics of caspofungin for general patients, intensive care unit patients and hepatic insufficiency patients. Acta Pharmacol Sin 2018;39:1533-43. [PMID: 29849129 DOI: 10.1038/aps.2017.176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Tse AH, Ling L, Lee A, Joynt GM. Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review. Clinical Therapeutics 2018;40:1598-1615.e2. [DOI: 10.1016/j.clinthera.2018.07.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
66 Devlin JW, Smithburger P, Kane JM, Fraser GL, Skrobik Y. Intended and Unintended Consequences of Constraining Clinician Prescribing: The Case of Antipsychotics. Crit Care Med 2016;44:1805-7. [PMID: 27635480 DOI: 10.1097/CCM.0000000000002103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
67 Kovacevic MP, Szumita PM, Dube KM, DeGrado JR. Transition From Continuous Infusion Fentanyl to Hydromorphone in Critically Ill Patients. J Pharm Pract 2020;33:129-35. [PMID: 29996718 DOI: 10.1177/0897190018786832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
68 Udy AA, Roberts JA, Lipman J, Blot S. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics. Adv Drug Deliv Rev 2018;123:65-74. [PMID: 28964882 DOI: 10.1016/j.addr.2017.09.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 8.5] [Reference Citation Analysis]
69 Moore S. Therapeutic Advances in the Management of Older Adults in the Intensive Care Unit: A Focus on Pain, Sedation, and Delirium. American Journal of Therapeutics 2018;25:e115-27. [DOI: 10.1097/mjt.0000000000000685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
70 Owen EJ, Gibson GA, Buckman SA. Pharmacokinetics and Pharmacodynamics of Antimicrobials in Critically Ill Patients. Surg Infect (Larchmt) 2018;19:155-62. [PMID: 29272204 DOI: 10.1089/sur.2017.262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
71 Shah AG, Peahota M, Thoma BN, Kraft WK. Medication Complications in Extracorporeal Membrane Oxygenation. Crit Care Clin 2017;33:897-920. [PMID: 28887935 DOI: 10.1016/j.ccc.2017.06.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
72 Boonstra JM, van der Elst KC, Veringa A, Jongedijk EM, Brüggemann RJ, Koster RA, Kampinga GA, Kosterink JG, van der Werf TS, Zijlstra JG, Touw DJ, Alffenaar JWC. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis. Antimicrob Agents Chemother 2017;61:e01398-17. [PMID: 28971861 DOI: 10.1128/AAC.01398-17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
73 Medellín-Garibay SE, Romano-Moreno S, Tejedor-Prado P, Rubio-Álvaro N, Rueda-Naharro A, Blasco-Navalpotro MA, García B, Barcia E. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients. Antimicrob Agents Chemother 2017;61:e01249-17. [PMID: 28893792 DOI: 10.1128/AAC.01249-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
74 Turnbull D, Singatullina N, Reilly C. A Systematic Appraisal of Neurosurgical Seizure Prophylaxis: Guidance for Critical Care Management. J Neurosurg Anesthesiol 2016;28:233-49. [PMID: 26192247 DOI: 10.1097/ANA.0000000000000206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
75 Maraolo AE, Cascella M, Corcione S, Cuomo A, Nappa S, Borgia G, De Rosa FG, Gentile I. Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art. Expert Review of Anti-infective Therapy 2017;15:861-71. [DOI: 10.1080/14787210.2017.1367666] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
76 Cies JJ, Moore WS 2nd, Enache A, Chopra A. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Meropenem in Critically Ill Young Children. J Pediatr Pharmacol Ther 2017;22:276-85. [PMID: 28943823 DOI: 10.5863/1551-6776-22.4.276] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
77 Zhao M, Tao J, Du L, Jiang S, Qian D, Duan J. UPLC-Q-TOF/MS-Based Metabolic Profiling Comparison of Two Major Bioactive Components and Their Metabolites in Normal and CKD Rat Plasma, Urine and Feces Following Oral Administration of Fructus Corni Extract. Journal of Chromatographic Science 2017;55:857-65. [DOI: 10.1093/chromsci/bmx046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
78 Poblete R, Sung G. Status Epilepticus and Beyond: A Clinical Review of Status Epilepticus and an Update on Current Management Strategies in Super-refractory Status Epilepticus. Korean J Crit Care Med 2017;32:89-105. [PMID: 31723624 DOI: 10.4266/kjccm.2017.00252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
79 Fuster-Lluch O, Zapater-Hernández P, Gerónimo-Pardo M. Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration. J Clin Pharmacol 2017;57:1345-52. [PMID: 28419483 DOI: 10.1002/jcph.903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
80 De Cock PAJG, van Dijkman SC, de Jaeger A, Willems J, Carlier M, Verstraete AG, Delanghe JR, Robays H, Vande Walle J, Della Pasqua OE, De Paepe P. Dose optimization of piperacillin/tazobactam in critically ill children. Journal of Antimicrobial Chemotherapy 2017;72:2002-11. [DOI: 10.1093/jac/dkx093] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
81 Garpestad E, Devlin JW. Polypharmacy and Delirium in Critically Ill Older Adults: Recognition and Prevention. Clin Geriatr Med 2017;33:189-203. [PMID: 28364991 DOI: 10.1016/j.cger.2017.01.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
82 Kleiber N, Mathôt RAA, Ahsman MJ, Wildschut ED, Tibboel D, de Wildt SN. Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration. Br J Clin Pharmacol 2017;83:1227-39. [PMID: 28078682 DOI: 10.1111/bcp.13235] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
83 Wang Y, Zhao M, Ye H, Shao Y, Yu Y, Wang M, Zhao C. Comparative pharmacokinetic study of the main components of cortex fraxini after oral administration in normal and hyperuricemic rats. Biomedical Chromatography 2017;31:e3934. [DOI: 10.1002/bmc.3934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
84 van der Elst KC, Veringa A, Zijlstra JG, Beishuizen A, Klont R, Brummelhuis-Visser P, Uges DR, Touw DJ, Kosterink JG, van der Werf TS, Alffenaar JC. Low Caspofungin Exposure in Patients in Intensive Care Units. Antimicrob Agents Chemother 2017;61:e01582-16. [PMID: 27855112 DOI: 10.1128/AAC.01582-16] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
85 Dillon RC, Witcher R, Cies JJ, Moore WS 2nd, Chopra A. Pharmacokinetics of Peramivir in an Adolescent Patient Receiving Continuous Venovenous Hemodiafiltration. J Pediatr Pharmacol Ther 2017;22:60-4. [PMID: 28337082 DOI: 10.5863/1551-6776-22.1.60] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
86 Tse AH, Ling L, Joynt GM, Lee A. Prolonged infusion of sedatives and analgesics in adult intensive care patients: A systematic review of pharmacokinetic data reporting and quality of evidence. Pharmacol Res 2017;117:156-65. [PMID: 28012962 DOI: 10.1016/j.phrs.2016.12.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
87 Veringa A, Geling S, Span LF, Vermeulen KM, Zijlstra JG, van der Werf TS, Kosterink JG, Alffenaar JC. Bioavailability of voriconazole in hospitalised patients. Int J Antimicrob Agents 2017;49:243-6. [PMID: 28012684 DOI: 10.1016/j.ijantimicag.2016.10.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
88 Villa G, Di Maggio P, De Gaudio AR, Novelli A, Antoniotti R, Fiaccadori E, Adembri C. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review. Crit Care 2016;20:374. [PMID: 27863531 DOI: 10.1186/s13054-016-1551-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
89 Stern ST, Martinez MN, Stevens DM. When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics? Drug Metab Dispos 2016;44:1934-9. [PMID: 27670412 DOI: 10.1124/dmd.116.073148] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
90 McLaughlin MM, Ammar AT, Gerzenshtein L, Scarsi KK. Dosing nucleoside reverse transcriptase inhibitors in adults receiving continuous veno-venous hemofiltration. Clin Drug Investig 2015;35:275-80. [PMID: 25691260 DOI: 10.1007/s40261-015-0275-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
91 Reardon DP, Anger KE, Szumita PM. Pathophysiology, assessment, and management of pain in critically ill adults. Am J Health Syst Pharm 2015;72:1531-43. [PMID: 26346209 DOI: 10.2146/ajhp140541] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
92 Hagihara M, Kato H, Hamada Y, Hirai J, Sakanashi D, Suematsu H, Nishiyama N, Koizumi Y, Yamagishi Y, Matsuura K, Mikamo H. Population pharmacokinetics of arbekacin in different infectious disease settings and evaluation of dosing regimens. J Infect Chemother 2016;22:436-43. [PMID: 27260679 DOI: 10.1016/j.jiac.2016.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
93 Franken LG, de Winter BC, van Esch HJ, van Zuylen L, Baar FP, Tibboel D, Mathôt RA, van Gelder T, Koch BC. Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol. Expert Opin Drug Metab Toxicol 2016;12:669-80. [PMID: 27081769 DOI: 10.1080/17425255.2016.1179281] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
94 Bassetti M, Luyt CE, Nicolau DP, Pugin J. Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient. Ann Intensive Care 2016;6:35. [PMID: 27090532 DOI: 10.1186/s13613-016-0140-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
95 Droege CA, Mueller EW. Fentanyl Pharmacokinetics in Critically Ill Patients: A Demonstration of Mixed Effects. Crit Care Med 2016;44:240-2. [PMID: 26672932 DOI: 10.1097/CCM.0000000000001444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
96 Scalese MJ, Herring HR, Rathbun RC, Skrepnek GH, Ripley TL. Propofol-associated QTc prolongation. Ther Adv Drug Saf 2016;7:68-78. [PMID: 27298717 DOI: 10.1177/2042098616641354] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
97 Yogaratnam D, Ditch K, Medeiros K, Miller MA, Smith BS. The Impact of Liver and Renal Dysfunction on the Pharmacokinetics and Pharmacodynamics of Sedative and Analgesic Drugs in Critically Ill Adult Patients. Crit Care Nurs Clin North Am 2016;28:183-94. [PMID: 27215356 DOI: 10.1016/j.cnc.2016.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Bassetti M, Welte T, Wunderink RG. Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair? Crit Care 2016;20:19. [PMID: 26821535 DOI: 10.1186/s13054-016-1197-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
99 Michael E, Kindgen-Milles D. [Antibiotic dosing for renal function disorders and continuous renal replacement therapy]. Anaesthesist 2015;64:315-23. [PMID: 25812546 DOI: 10.1007/s00101-015-0008-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
100 Stoetzer C, Reuter S, Doll T, Foadi N, Wegner F, Leffler A. Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine. Naunyn Schmiedebergs Arch Pharmacol 2016;389:315-25. [PMID: 26667357 DOI: 10.1007/s00210-015-1195-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
101 Zhao M, Tao J, Qian D, Liu P, Shang EX, Jiang S, Guo J, Su SL, Duan JA, Du L. Simultaneous determination of loganin, morroniside, catalpol and acteoside in normal and chronic kidney disease rat plasma by UPLC-MS for investigating the pharmacokinetics of Rehmannia glutinosa and Cornus officinalis Sieb drug pair extract. J Chromatogr B Analyt Technol Biomed Life Sci 2016;1009-1010:122-9. [PMID: 26720701 DOI: 10.1016/j.jchromb.2015.12.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
102 Lim WS, Brittain C, Duley L, Edwards S, Gordon S, Montgomery A, Nguyen-Van-Tam J, Read R, Whitham D, Whynes D, Woodhead M, Wootton D. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. Health Technol Assess 2015;19:1-78, vii-viii. [PMID: 25716702 DOI: 10.3310/hta19160] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
103 Kim DW, Kim T, Ji M, Chun YI. Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid Hemorrhage. Clinical Neuropharmacology 2015;38:248-51. [DOI: 10.1097/wnf.0000000000000112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
104 Thakuria L, Packwood K, Firouzi A, Rogers P, Soresi S, Habibi-Parker K, Lyster H, Zych B, Garcia-Saez D, Mohite P, Patil N, Sabashnikov A, Capoccia M, Chibvuri M, Lamba H, Tate H, Carby M, Simon A, Leaver N, Reed A. A pharmacokinetic analysis of posaconazole oral suspension in the serum and alveolar compartment of lung transplant recipients. Int J Antimicrob Agents 2016;47:69-76. [PMID: 26607341 DOI: 10.1016/j.ijantimicag.2015.09.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
105 Spoorenberg SM, Deneer VH, Grutters JC, Pulles AE, Voorn GP, Rijkers GT, Bos WJ, van de Garde EM. Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. Br J Clin Pharmacol 2014;78:78-83. [PMID: 24400953 DOI: 10.1111/bcp.12295] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
106 Zaal IJ, Devlin JW, Hazelbag M, Klein Klouwenberg PM, van der Kooi AW, Ong DS, Cremer OL, Groenwold RH, Slooter AJ. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med. 2015;41:2130-2137. [PMID: 26404392 DOI: 10.1007/s00134-015-4063-z] [Cited by in Crossref: 107] [Cited by in F6Publishing: 112] [Article Influence: 15.3] [Reference Citation Analysis]
107 De Cock PA, Standing JF, Barker CI, de Jaeger A, Dhont E, Carlier M, Verstraete AG, Delanghe JR, Robays H, De Paepe P. Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children. Antimicrob Agents Chemother 2015;59:7027-35. [PMID: 26349821 DOI: 10.1128/AAC.01368-15] [Cited by in Crossref: 43] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
108 Rostas JW, Brevard SB, Ahmed N, Allen J, Thacker D, Replogle WH, Gonzalez RP, Frotan AM, Simmons JD. Standard Dosing of Enoxaparin for Venous Thromboembolism Prophylaxis is Not Sufficient for Most Patients within a Trauma Intensive Care Unit. The American Surgeon 2015;81:889-92. [DOI: 10.1177/000313481508100923] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
109 Tao J, Zhao M, Wang D, Yang C, Chen G, Zhao X, Pu X, Jiang S. UPLC-Q-TOF/MS-based screening and identification of two major bioactive components and their metabolites in normal and CKD rat plasma, urine and feces after oral administration of Rehmannia glutinosa Libosch extract. Journal of Chromatography B 2015;1001:98-106. [DOI: 10.1016/j.jchromb.2015.07.035] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
110 Tansley G, Hall R. Pharmacokinetic considerations for drugs administered in the critically ill. Br J Hosp Med (Lond) 2015;76:89-94. [PMID: 25671473 DOI: 10.12968/hmed.2015.76.2.89] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
111 Nei SD, Wittwer ED, Kashani KB, Frazee EN. Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation. Pharmacotherapy 2015;35:e127-30. [PMID: 26242293 DOI: 10.1002/phar.1615] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
112 Zhao M, Qian D, Liu P, Shang EX, Jiang S, Guo J, Su SL, Duan JA, Du L, Tao J. Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract. Biomed Chromatogr 2015;29:1842-8. [PMID: 26031219 DOI: 10.1002/bmc.3505] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
113 Blackburn LM, Tverdek FP, Hernandez M, Bruno JJ. First-dose pharmacokinetics of aminoglycosides in critically ill haematological malignancy patients. International Journal of Antimicrobial Agents 2015;45:46-53. [DOI: 10.1016/j.ijantimicag.2014.09.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
114 Yang Q, Wang T, Xie J, Chen L, Wang Y, Cheng X, Dong H, Dong W, Wei Y, Wang X, Dong Y. A sensitive liquid chromatography-tandem mass spectrometry method for monitoring the caspofungin trough plasma concentration and its association with caspofungin efficacy in intensive-care-unit patients. RSC Adv 2015;5:104806-14. [DOI: 10.1039/c5ra21080a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
115 Yusuf E, Spapen H, Piérard D. Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: A narrative and systematic review. Journal of Critical Care 2014;29:1089-95. [DOI: 10.1016/j.jcrc.2014.07.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
116 Hites M, Dell'Anna AM, Scolletta S, Taccone FS. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients. Adv Drug Deliv Rev 2014;77:12-21. [PMID: 24842474 DOI: 10.1016/j.addr.2014.05.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
117 Blot SI, Pea F, Lipman J. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev 2014;77:3-11. [PMID: 25038549 DOI: 10.1016/j.addr.2014.07.006] [Cited by in Crossref: 250] [Cited by in F6Publishing: 224] [Article Influence: 31.3] [Reference Citation Analysis]
118 Franconi F, Rosano G, Campesi I. Need for gender-specific pre-analytical testing: the dark side of the moon in laboratory testing. Int J Cardiol 2015;179:514-35. [PMID: 25465806 DOI: 10.1016/j.ijcard.2014.11.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
119 Lewis SJ, Mueller BA. Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much". J Intensive Care Med 2016;31:164-76. [PMID: 25326429 DOI: 10.1177/0885066614555490] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
120 Muilwijk EW, Schouten JA, van Leeuwen HJ, van Zanten ARH, de Lange DW, Colbers A, Verweij PE, Burger DM, Pickkers P, Brüggemann RJM. Pharmacokinetics of caspofungin in ICU patients. Journal of Antimicrobial Chemotherapy 2014;69:3294-9. [DOI: 10.1093/jac/dku313] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
121 Kennelly C, Esaian D. Drug-induced cardiovascular adverse events in the intensive care unit. Crit Care Nurs Q 2013;36:323-34. [PMID: 24002423 DOI: 10.1097/CNQ.0b013e3182a10c2a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
122 Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol 2014;25:1897-907. [PMID: 24812165 DOI: 10.1681/ASN.2013101062] [Cited by in Crossref: 325] [Cited by in F6Publishing: 369] [Article Influence: 40.6] [Reference Citation Analysis]
123 Plummer MP, Chapman MJ, Horowitz M, Deane AM. Incretins and the intensivist: what are they and what does an intensivist need to know about them? Crit Care 2014;18:205. [PMID: 24602388 DOI: 10.1186/cc13737] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
124 Dixon J, Lane K, Macphee I, Philips B. Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism. Int J Mol Sci 2014;15:2538-53. [PMID: 24531139 DOI: 10.3390/ijms15022538] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
125 Olesen AE, Brokjaer A, Fisher IW, Larsen IM. Pharmacological challenges in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7302-7307 [PMID: 24259961 DOI: 10.3748/wjg.v19.i42.7302] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
126 Philips BJ, Lane K, Dixon J, Macphee I. The effects of acute renal failure on drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 2013;10:11-23. [DOI: 10.1517/17425255.2013.835802] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
127 Davis SL, Scheetz MH, Bosso JA, Goff DA, Rybak MJ. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals. Pharmacotherapy. 2013;33:1256-1263. [PMID: 23897602 DOI: 10.1002/phar.1327] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
128 Udy AA, Roberts JA, Lipman J. How should we dose antibiotics for pneumonia in the ICU? Curr Opin Infect Dis 2013;26:189-95. [PMID: 23434897 DOI: 10.1097/QCO.0b013e32835d19e0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
129 Roberts DJ, Hall RI. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults. Expert Opin Drug Metab Toxicol 2013;9:1067-84. [PMID: 23682923 DOI: 10.1517/17425255.2013.799137] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
130 Greenberg SB, Vender J. The Use of Neuromuscular Blocking Agents in the ICU: Where Are We Now? Critical Care Medicine 2013;41:1332-44. [DOI: 10.1097/ccm.0b013e31828ce07c] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
131 Bhalodi AA, Keel RA, Quintiliani R, Lodise TP, Nicolau DP, Kuti JL. Pharmacokinetics of Doripenem in Infected Patients Treated Within and Outside the Intensive Care Unit. Ann Pharmacother 2013;47:617-27. [DOI: 10.1345/aph.1r789] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
132 Gurevich KG. Effect of blood protein concentrations on drug-dosing regimes: practical guidance. Theor Biol Med Model 2013;10:20. [PMID: 23506635 DOI: 10.1186/1742-4682-10-20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
133 Bhalodi AA, Papasavas PK, Tishler DS, Nicolau DP, Kuti JL. Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adults. Antimicrob Agents Chemother 2013;57:1144-9. [PMID: 23254421 DOI: 10.1128/AAC.01453-12] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]